Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 17601

1.

Low bone mineral density predicts the formation of new syndesmophytes in patients with axial spondyloarthritis.

Kim HR, Hong YS, Park SH, Ju JH, Kang KY.

Arthritis Res Ther. 2018 Oct 16;20(1):231. doi: 10.1186/s13075-018-1731-8.

PMID:
30326956
2.

The Relationship between the Occipitocervical Junction and Thoracic Kyphosis in Ankylosing Spondylitis: A Retrospective Cohort Study of 86 Cervical Fractures in Surgically Treated Patients.

Manabe N, Covaro A, Bobinski L, Shimizu T, Olerud C, Robinson Y.

Asian Spine J. 2018 Oct 18. doi: 10.31616/asj.2018.0010. [Epub ahead of print]

PMID:
30326690
3.

Low Levels of Renin and High Aldosterone-to-Renin Ratio Among Rheumatoid Patients and Ankylosing Spondylitis Patients: A Prospective Study.

Guy A, Sharif K, Luigi Bragazzi N, Krosser A, Gilburd B, Zeruya E, Shovman O, Watad A, Amital H.

Isr Med Assoc J. 2018 Oct;20(10):632-636.

5.

Exploring strategies to support medication adherence in patients with inflammatory arthritis: a patient-oriented qualitative study using an interactive focus group activity.

Rai SK, Howren A, Wilcox ES, Townsend AF, Marra CA, Aviña-Zubieta JA, De Vera MA.

Patient Prefer Adherence. 2018 Oct 5;12:2015-2025. doi: 10.2147/PPA.S174672. eCollection 2018.

6.

A descriptive analysis of real-world treatment patterns of innovator (Remicade®) and biosimilar infliximab in an infliximab-naïve Turkish population.

Yazici Y, Xie L, Ogbomo A, Ellis LA, Goyal K, Teeple A, Mutlu EA, Simsek I.

Biologics. 2018 Oct 2;12:97-106. doi: 10.2147/BTT.S172241. eCollection 2018.

7.

Differences in Palmoplantar Pustulosis and Psoriasis Vulgaris in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis Treated with Biological Therapy.

Ruwaard J, van der Vlugt ER, Wolbink G.

J Rheumatol. 2018 Oct 15. pii: jrheum.180566. doi: 10.3899/jrheum.180566. [Epub ahead of print]

PMID:
30323005
8.

Association between cytokine gene polymorphisms and ankylosing spondylitis susceptibility: a systematic review and meta-analysis.

Xia Y, Liang Y, Guo S, Yu JG, Tang MS, Xu PH, Qin FD, Wang GP.

Postgrad Med J. 2018 Oct 15. pii: postgradmedj-2018-135665. doi: 10.1136/postgradmedj-2018-135665. [Epub ahead of print]

PMID:
30322951
9.

Management of Andersson Lesion in Ankylosing Spondylitis Using the Posterior-Only Approach: A Case Series of 18 Patients.

Shaik I, Bhojraj SY, Prasad G, Nagad PB, Patel PM, Kashikar AD, Kumar N.

Asian Spine J. 2018 Oct 16. doi: 10.31616/asj.2018.12.6.1017. [Epub ahead of print]

10.

Identification of key genes in Ankylosing spondylitis.

Xu ZY, Zhou C, Zhang KF, Zheng YP.

Immunol Lett. 2018 Oct 12. pii: S0165-2478(18)30017-8. doi: 10.1016/j.imlet.2018.03.016. [Epub ahead of print]

PMID:
30321561
11.

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.

Torres L, Klingberg E, Nurkkala M, Carlsten H, Forsblad-d'Elia H.

Osteoporos Int. 2018 Oct 10. doi: 10.1007/s00198-018-4721-4. [Epub ahead of print]

PMID:
30306221
12.

Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project.

Ikdahl E, Rollefstad S, Wibetoe G, Salberg A, Krøll F, Bergsmark K, Kvien TK, Olsen IC, Soldal DM, Bakland G, Lexberg Å, Gjesdal CG, Gulseth C, Haugeberg G, Semb AG.

RMD Open. 2018 Oct 1;4(2):e000737. doi: 10.1136/rmdopen-2018-000737. eCollection 2018.

13.

The microbiome and HLA-B27-associated acute anterior uveitis.

Rosenbaum JT, Asquith M.

Nat Rev Rheumatol. 2018 Oct 9. doi: 10.1038/s41584-018-0097-2. [Epub ahead of print] Review.

PMID:
30301938
14.

Clinical and genetic characteristics of ankylosing spondylitis patients with peripheral arthritis at disease onset.

Polo Y La Borda J, Szczypiorska M, Bartolomé N, Campos J, Flores-Robles BJ, Sanz J, Fernández-Espartero C, Clavaguera T, Andrus RF, Artieda M, Tejedor D, Martínez A, Mulero J, Isasi CM, Andréu JL, Sánchez A.

Clin Exp Rheumatol. 2018 Sep 17. [Epub ahead of print]

PMID:
30299251
15.

Imaging of axial spondyloarthritis. New aspects and differential diagnoses.

Braun J, Baraliakos X, Buehring B, Kiltz U, Fruth M.

Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):35-42. Epub 2018 Oct 1. Review.

16.

Sacroiliac Joint Ankylosis In Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial MRI scans.

Bray TJP, Lopes A, Fisher C, Ciurtin C, Sen D, Hall-Craggs MA.

Arthritis Rheumatol. 2018 Oct 8. doi: 10.1002/art.40750. [Epub ahead of print]

PMID:
30295426
17.

Etanercept-induced Crohn's disease in ankylosing spondylitis: a case report and review of the literature.

Tolu S, Rezvani A, Hindioglu N, Calkin Korkmaz M.

Rheumatol Int. 2018 Oct 6. doi: 10.1007/s00296-018-4165-3. [Epub ahead of print] Review.

PMID:
30293157
18.
19.

Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.

Arévalo M, Gratacós Masmitjà J, Moreno M, Calvet J, Orellana C, Ruiz D, Castro C, Carreto P, Larrosa M, Collantes E, Font P; REGISPONSER group.

Arthritis Res Ther. 2018 Oct 3;20(1):221. doi: 10.1186/s13075-018-1724-7.

20.

PF-06438179/GP1111: An Infliximab Biosimilar.

Al-Salama ZT.

BioDrugs. 2018 Oct 4. doi: 10.1007/s40259-018-0310-5. [Epub ahead of print]

PMID:
30284704

Supplemental Content

Loading ...
Support Center